OCUL — Ocular Therapeutix Cashflow Statement
0.000.00%
Last trade - 00:00- $1.98bn
- $1.31bn
- $51.95m
- 63
- 13
- 28
- 25
Annual cashflow statement for Ocular Therapeutix, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -6.55 | -71 | -80.7 | -194 | -266 |
| Depreciation | |||||
| Non-Cash Items | -58.5 | 7.98 | 14.9 | 65.3 | 49 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -2.9 | 1.35 | -7.41 | -10.2 | 7.71 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -65.5 | -59.6 | -70.2 | -135 | -205 |
| Capital Expenditures | -1.19 | -3.71 | -6.09 | -1.29 | -12 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | — | — | — | 0.13 |
| Sale of Fixed Assets | |||||
| Cash from Investing Activities | -1.19 | -3.71 | -6.09 | -1.29 | -11.9 |
| Financing Cash Flow Items | — | — | -5.18 | — | 0 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 2.85 | 1.45 | 170 | 332 | 562 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -63.9 | -61.9 | 93.5 | 196 | 345 |